Literature DB >> 1925514

Port-A-Cath: a study of complication rates.

M O Robinson1, P Halverson.   

Abstract

Venous access can be a difficult problem for patients receiving intravenous medications, such as chemotherapy, over long periods of time. Totally implanted venous access devices, such as the Port-A-Cath TM (Pharmacia Deltec, St. Paul, MN) have been introduced as a solution to the problem of venous access. These devices are marketed as a safe, reliable method of venous access. Between January 1986 and December 1988, one hundred sixty patients had Port-A-Caths implanted at Sioux Valley Hospital. The medical records of these patients were reviewed to determine the type and rates of complications with the Port-A-Cath. Complications included pneumothoracies, extravasation of injected substances, difficulty aspirating blood, occlusion and sepsis. This article describes the results of our study and a review of the literature.

Entities:  

Mesh:

Year:  1991        PMID: 1925514

Source DB:  PubMed          Journal:  S D J Med


  3 in total

1.  [The clinical and pharmacokinetic results of intrapleural epirubicin application].

Authors:  R B Schilcher; A N Rahn; M E Scheulen
Journal:  Strahlenther Onkol       Date:  1997-04       Impact factor: 3.621

Review 2.  Totally implantable catheter migration and its percutaneous retrieval: case report and review of the literature.

Authors:  E Intagliata; F Basile; R Vecchio
Journal:  G Chir       Date:  2017 Sep-Oct

3.  The use of port-a-caths in adult patients with Lysosomal Storage Disorders receiving Enzyme Replacement Therapy-one centre experience.

Authors:  Mairead McLoughlin; Karolina M Stepien; Briony McNelly; Lorraine Thompson; Janet Gorton; Christian J Hendriksz
Journal:  Mol Genet Metab Rep       Date:  2017-10-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.